Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
GPCR
Stock Latest News
Ratings
Analyst Maintains Buy on Strong Aleniglipron Data and 2026 Catalysts, Modestly Trimming Price Target to $104
16d ago
GPCR
Premium
Company Announcements
Structure Therapeutics Expands ATM Capacity, Advances Obesity Program
17d ago
8K
GPCR
Premium
The Fly
Canaccord starts Structure Therapeutics on oral weight loss pipeline
27d ago
GPCR
Premium
The Fly
Structure Therapeutics initiated with a Buy at Canaccord
27d ago
GPCR
Premium
Market News
Kailera Stock (KLRA) Rockets 68% after IPO in Race for $150B Obesity Market
1M ago
LLY
PFE
Premium
Company Announcements
Structure Therapeutics Appoints Matthew Lang as Chief Operating Officer
1M ago
8K
GPCR
Premium
The Fly
Structure Therapeutics appoints Matthew Lang as COO
1M ago
GPCR
Premium
Ratings
Buy Rating on GPCR Driven by Competitive Aleniglipron Phase 2b Efficacy and Clear Path to Phase 3 in Obesity
2M ago
GPCR
Premium
The Fly
Structure Therapeutics price target lowered to $100 from $114 at H.C. Wainwright
2M ago
GPCR
Premium
Ratings
Buy Rating on Structure Therapeutics: Aleniglipron’s Strengthening Clinical Profile and Undervalued Global Obesity Opportunity
2M ago
GPCR
Premium
The Fly
Structure’s GLP-1 pill could put company on M&A radar, Barron’s says
2M ago
LLY
NVO
Premium
Company Announcements
Structure Therapeutics Reports Strong Phase 2 Obesity Drug Results
2M ago
8K
GPCR
Premium
The Fly
Structure Therapeutics: Aleniglipron achieved meaningful weight loss in study
2M ago
GPCR
Premium
Ratings
Leveraging External Amylin Validation: Positioning Structure Therapeutics’ Amylin and Oral GLP‑1 Platform for Combination-Driven Upside
3M ago
GPCR
Premium
The Fly
Structure Therapeutics price target raised to $114 from $90 at H.C. Wainwright
3M ago
GPCR
Premium
The Fly
Structure Therapeutics price target lowered to $113 from $120 at Citizens
3M ago
GPCR
Premium
Ratings
Buy Rating on Structure Therapeutics: Strong Phase II Data and Upcoming Late‑Stage Catalysts Support Upside for Oral GLP‑1 Aleniglipron
3M ago
GPCR
Premium
The Fly
Midday Fly By: Warsh nominated for Fed chair, Apple reports Q1 beat
4M ago
V
CL
Premium
The Fly
Structure Therapeutics emerges as top M&A target for big pharma, Axios says
4M ago
GPCR
Premium
The Fly
Structure Therapeutics price target raised to $105 from $65 at JPMorgan
4M ago
GPCR
Premium
The Fly
Structure Therapeutics price target raised to $140 from $90 at Guggenheim
4M ago
GPCR
Premium
The Fly
Structure Therapeutics moved to Buy rating at Goldman Sachs
4M ago
LLY
GPCR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
